Lateral flexion in Parkinson's disease and Pisa syndrome

Journal of Neurology

Volumn 253, Issue SUPPL. 7, 2006, Pages

  Yokochi, Fusako ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Dopamine agonist; Lateral flexion posture; Oblique sign; Parkinson's disease; Pisa syndrome

Indexed keywords

ANTIEMETIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LITHIUM CARBONATE; NEUROLEPTIC AGENT; PERGOLIDE; PRAMIPEXOLE; SEROTONIN UPTAKE INHIBITOR; TIAPRIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

BODY POSTURE; CHRONICITY; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG RESPONSE; DYSTONIA; FLEXION CONTRACTURE; HUMAN; LATERAL FLEXION; PARKINSON DISEASE; PISA SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYMPTOM;

DYSKINESIAS; DYSTONIA; HUMANS; PARKINSON DISEASE; POSTURE;

EID: 33751544059     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-7005-4     Document Type: Review

References (16)

1. Duvoisin RC, Marsden CD (1975) Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry 38(8):787-793
2. Marsden CD, Duvoisin R (1980) Scoliosis and Parkinson's disease. Arch Neurol 37(4):253-254
3. Furukawa T (1986) The oblique signs of Parkinsonism. Neurol Med 25:11-13
4. Furukawa T, Okiyama R, Tsukagoshi H (1989) Oblique sign of Parkisonism. Clin Neurol 29:1603
5. Furukawa T (2001) Body schema. Neurol Med 54:472-478
6. DLee AC, Harris JP, Atkinson EA, Fowler MS (2001) Disruption of estimation of body-scaled aperture width in Hemiparkinson's disease. Neuropsychologia 39(10):1097-1104
7. DProctor F, Riklan M, Cooper IS et al. (1964) Judgment of visual and postural vertical by parkinsonian patients. Neurology 14:287-293
8. Ekbom K, Lindholm H, Ljungberg L (1972) New dystonic syndrome associated with butyrophenone therapy. Z Neurol 202(2):94-103
9. Yassa R, Nastase C, Cvejic J et al. (1991) The Pisa syndrome (or pleurothotonus): prevalence in a psychogeriatric population. Biol Psychiatry 29(9):942-945
10. Stubner S, Padberg F, Grohmann R et al. (2000) Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 61(8):569-574
11. Suzuki T, Matsuzaka H (2002) Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 16(3):165-174
12. Suzuki T, Hori T, Baba A et al. (1999) Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome). J Clin Psychopharm 19(3):277-280
13. Villarejo A, Camacho A, Garcia-Ramos R et al. (2003) Cholinergic- dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 26(3):119-121
14. Cannas A, Solla P, Floris G et al. (2005) Reversible Pisa syndrome in Parkinson's disease during treatment with Pergolide: a case report. Clin Neuropharm 28(5):252
15. Gambarin M, Antonini A, Moretto G et al. (2006) Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: case report. Mov Disord 21(2):270-273
16. Herrera-Marschitz M, Utsumi H, Ungerstedt U (1990) Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation. J Neurol Neurosurg Psychiatry 53(1):39-43